Predictive factors associated with prolonged survival in patients with advanced non-smallcell lung cancer (NSCLC) treated with gefitinib

被引：0
|
作者：
Satouchi, Miyako
Funada, Yasuhiro
Urata, Yoshiko
Shimada, Temiko
Yoshimura, Sho
Watanabe, Hirokazu
Kurata, Takayasu
Adachi, Shuji
Takada, Yoshiki
Negoro, Shunichi
机构：
[1] Hyogo Med Ctr Adults, Akashi, Hyogo, Japan
[2] Hyogo Med Ctr Adults, Akashi, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [1] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    Satouchi, M.
    Negoro, S.
    Funada, Y.
    Urata, Y.
    Shimada, T.
    Yoshimura, S.
    Kotani, Y.
    Sakuma, T.
    Watanabe, H.
    Adachi, S.
    Takada, Y.
    Yatabe, Y.
    Mitsudomi, T.
    BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1191 - 1196
  • [2] Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
    M Satouchi
    S Negoro
    Y Funada
    Y Urata
    T Shimada
    S Yoshimura
    Y Kotani
    T Sakuma
    H Watanabe
    S Adachi
    Y Takada
    Y Yatabe
    T Mitsudomi
    British Journal of Cancer, 2007, 96 : 1191 - 1196
  • [3] Atezolizumab in previously treated non-smallcell lung cancer patients
    Serino, Mariana
    Santos, Vanessa
    Araujo, David
    Novais-Bastos, Helder
    Magalhaes, Adriana
    Fernandes, Gabriela
    Queiroga, Henrique
    Hespanhol, Venceslau
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [4] PREDICTIVE FACTORS ASSOCIATED WITH GEFITINIB RESPONSE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Xu, F.
    Zhou, T.
    Duan, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
  • [5] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer (NSCLC)
    Chen, Lian
    Chen, Rui
    Zhu, Zhe
    Zhang, Yichen
    Wen, Zhengwei
    Li, Yun
    Li, Xiaoming
    Luo, Yuwen
    Ma, Liyu
    Lin, Shuguang
    Chen, Xin
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 466 - 470
  • [6] Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer(NSCLC)
    Lian Chen
    Rui Chen
    Zhe Zhu
    Yichen Zhang
    Zhengwei Wen
    Yun Li
    Xiaoming Li
    Yuwen Luo
    Liyu Ma
    Shuguang Lin
    Xin Chen
    Chinese Journal of Cancer Research, 2014, 26 (04) : 466 - 470
  • [7] FoxM1 mediated resistance to gefitinib in non-smallcell lung cancer cells
    Nuo Xu
    Xin Zhang
    Xun Wang
    Hai-yan Ge
    Xiao-ying Wang
    David Garfield
    Ping Yang
    Yuan-lin Song
    Chun-xue Bai
    Acta Pharmacologica Sinica, 2012, 33 : 675 - 681
  • [8] Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or Erlotinib
    Tsujino, Kazuyuki
    Kawaguchi, Tomoya
    Kubo, Akihito
    Aono, Nana
    Nakao, Keiko
    Koh, Yasuhiro
    Tachibana, Kazunobu
    Isa, Shun-ichi
    Takada, Minoru
    Kurata, Takayasu
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (08) : 994 - 1001
  • [9] Does Smoking Status Affect Survival After Chemoradiotherapy for Locally Advanced Non-SmallCell Lung Cancer?
    Wallace, N. D.
    Alexander, M.
    Xie, S.
    Ball, D.
    Solomon, B.
    Plumridge, N.
    Shaw, M.
    Harden, S.
    Hegi-Johnson, F.
    Siva, S.
    John, T.
    Officer, A.
    MacManus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S105 - S106
  • [10] Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-SmallCell Lung Cancer in a Tertiary Referral Hospital
    Kim, Seo Woo
    Kim, Mi Yeon
    Lee, Yoon Pyo
    Ryu, Yon Ju
    Lee, Seok Jeong
    Lee, Jin Hwa
    Chang, Jung Hyun
    Shim, Sung Shine
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (02) : 52 - 58
12345